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Defective ENaC processing and function in tissue
kallikrein-deficient mice
Abstract
An inverse relationship exists between urinary tissue kallikrein (TK) excretion and blood pressure in
humans and rodents. In the kidney TK is synthesized in large amounts in the connecting tubule and is
mainly released into the urinary fluid where its function remains unknown. In the present study mice
with no functional gene coding for TK (TK-/-) were used to test whether the enzyme regulates apically
expressed sodium transporters. Semiquantitative immunoblotting of the renal cortex revealed an absence
of the 70-kDa form of gamma-ENaC in TK-/- mice. Urinary Na+ excretion after amiloride injection was
blunted in TK-/- mice, consistent with reduced renal ENaC activity. Amiloride-sensitive transepithelial
potential difference in the colon, where TK is also expressed, was decreased in TK-/- mice, whereas
amiloride-sensitive alveolar fluid clearance in the lung, where TK is not expressed, was unchanged. In
mice lacking the B2 receptor for kinins, the abundance of the 70-kDa form of gamma-ENaC was
increased, indicating that its absence in TK-/- mice is not kinin-mediated. Incubation of membrane
proteins from renal cortex of TK-/- mice with TK resulted in the appearance of the 70-kDa band of the
gamma-ENaC, indicating that TK was able to promote gamma-ENaC cleavage in vitro. Finally, in
mouse cortical collecting ducts isolated and microperfused in vitro, the addition of TK in the luminal
fluid increased significantly intracellular Na+ concentration, consistent with an activation of the luminal
entry of the cation. The results demonstrate that TK, like several other proteases, can activate ENaC in
the kidney and the colon. 
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An inverse relationship exists between urinary 
tissue kallikrein (TK) excretion and blood 
pressure in humans and rodents. In the kidney, 
TK is synthesized in large amounts in the 
connecting tubule and is mainly released into the 
urinary fluid where its function remains 
unknown. In the present study, mice with no 
functional gene coding for TK (TK
-/-
) were used 
to test whether the enzyme regulates apically 
expressed sodium transporters. Semiquanti- 
tative immunoblotting of the renal cortex 
revealed an absence of the 70 kDa form of  -
ENaC in TK
-/-
 mice. Urinary Na
+
 excretion 
following amiloride injection was blunted in   
TK
-/-
 mice, consistent with reduced renal ENaC 
activity. Amiloride-sensitive transepithelial 
potential difference in the colon, where TK is 
also expressed, was decreased in TK
-/-
 mice 
whereas amiloride-sensitive alveolar fluid 
clearance in the lung, where TK is not 
expressed, was unchanged. In mice lacking the 
B2 receptor for kinins, the abundance of the 70 
kDa form of -ENaC was increased, indicating 
that its absence in TK
-/-
 mice is not kinin-
mediated. Incubation of membrane proteins 
from renal cortex of TK
-/-
 mice with TK resulted 
in the appearance of the 70 kDa band of the  -
ENaC, indicating that TK was able to promote 
-ENaC cleavage in vitro. Finally, in mouse 
cortical collecting ducts isolated and 
microperfused in vitro, addition of TK in the 
luminal fluid increased significantly 
intracellular Na
+
 concentration, consistent with 
an activation of the luminal entry of the cation. 
The results demonstrate that TK, like several 
other proteases can activate ENaC in the kidney 
and the colon.  
 
    Tissue kallikrein* (TK) is a serine protease that 
generates kinins locally in many organs, including 
the kidney, colon and arteries. In the kidney, TK 
which is synthesized in large amounts by 
connecting tubule cells (1) is mainly secreted into 
the urinary fluid and to a lesser extent to the 
peritubular interstitium. In the renal interstitium, it 
cleaves locally produced kininogen to yield 
bradykinin that in turn can activate type-2 (B2) 
bradykinin receptors. Bradykinin-dependent 
activation of B2 receptor increases sodium 
excretion by inhibiting sodium reabsorption in the 
collecting duct (2). Therefore, the renal kallikrein-
kinin system is expected to play a role in renal 
NaCl balance and blood pressure regulation. 
Patients with essential hypertension have lower 
kallikrein levels in their urine (3,4) and mutant 
mice lacking B2 receptor also exhibit salt-sensitive 
hypertension (5). However, inactivation of the TK 
gene in the mouse does not alter blood pressure (6) 
even though the decrease in renal and urinary 
kallikrein activity in TK-deficient mice reproduces 
the phenotype that has been repeatedly associated 
with hypertension in human and rat studies (7-9). 
This finding suggests that low urinary kallikrein 
excretion observed in hypertensive patients is not a 
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primary cause of high blood pressure (HBP) but 
rather a consequence of hypertension, or of HBP-
associated renal defects. An alternative explanation 
is that TK-deficient mice develop compensatory 
mechanisms to keep blood pressure at normal 
levels.  
     The role of the large amount of TK that is 
secreted into the urinary fluid remains unknown. 
One possibility would be that this protease acts 
directly on the different transporters expressed at 
the apical side of the tubular cells to modulate their 
activities. Apical sodium reabsorption along the 
renal tubule is achieved through multiple sodium 
transporters. Particularly, in the aldosterone-
sensitive distal nephron (ASDN, i.e., distal 
convoluted tubule (DCT2), connecting tubule 
(CNT) and collecting duct), the amiloride-sensitive 
epithelial Na
+
 channel ENaC, consisting of -, -, 
and -subunits, mediates Na+ uptake across the 
apical plasma membrane of principal cells and 
connecting tubule cells (10). In all renal tubule 
cells, the Na
+
 is extruded on the basolateral side in 
exchange for K
+
 by the Na
+
,K
+
-ATPase. Although 
sodium transport occurs throughout the length of 
the renal tubule, the fine regulation of sodium 
excretion occurs in the ASDN, mostly through 
aldosterone-dependent regulation of ENaC.  
     As TK production localizes to CNT cells, the 
urinary side of connecting and collecting duct cells, 
where ENaC is expressed, is exposed to large 
amounts of the active enzyme. Because a novel 
mechanism of proteolytic activation of ENaC by 
locally produced serine protease has been recently 
proposed (11,12), we hypothesized that TK might 
be a paracrine regulator acting directly on ENaC 
within the ASDN. To test this hypothesis, we used 
a mouse model with TK gene disruption (TK
-/-
) to 
study molecular and functional expression of 
ENaC.  
 
EXPERIMENTAL PROCEDURES 
 
Animals. The TK
-/-
 mice were previously generated 
in our laboratory (6). Type 2-bradykinin receptor 
knock out mice (B2
-/-
) mice were obtained from the 
Jackson Laboratory (Bar Harbor, Maine) (13).  In 
all experiments, controls consisted in wild type 
littermates (WT). All the experimental procedures 
were performed in accordance with the French 
Government animal welfare policy (Agreement 
number RA024647151FR).  
Aldosterone infusion study. 7 TK
-/-
 and 7 WT mice 
were infused continuously with aldosterone 100 
g.kg body wt-1.day-1 diluted in 0.9% NaCl and 5% 
DMSO administrated by osmotic minipump (Alzet 
model 2004, Durect corp., Cupertino, CA). In this 
particular set of experiments standard laboratory 
diet was supplemented with 3% Na
+
 and 0.4% K
+
. 
Control mice received vehicle alone. Infusion of 
aldosterone or vehicule were continued over a 28-
days period.  
Physiological studies. Animals were housed in 
metabolic cages and were pair-fed. After 3-5 days 
adaptation, urines were collected daily for 
electrolyte measurements. Animals were sacrificed 
with Ketamine and Xylazine (0.1 and 0.01 mg . g 
body wt
-1
, respectively). Plasma and urine 
electrolytes, creatinine, and aldosterone were 
determined as described (14). Plasma renin 
concentration (PRC) was determined by RIA of 
angiotensin I, generated by incubation of the 
plasma at pH 8.5 in the presence of an excess of rat 
angiotensinogen (15). Plasma atrial natriuretic 
peptide (ANP) concentration was measured by 
radioimmunoassay (Amersham, Arlington Heights, 
IL). 
Membrane fraction preparation. At the time of the 
sacrifice, kidneys were removed and cut into 5-mm 
slices. The renal cortex was excised under a 
stereoscopic microscope and placed into ice-cold 
isolation buffer (250 mM sucrose, 20 mM Tris-
Hepes, pH 7.4) containing protease inhibitors in 
g/ml: 4 aprotinin, 4 leupeptin, 1.5 pepstatin A and 
28 4-(2-aminoethyl)-benzenesulfonyl fluoride 
(AEBSF).  Lung were also removed, minced and 
placed in the same ice-cold isolation buffer. Minced 
tissues were homogenized in a Dounce 
homogenizer (pestle A, 5 passes) followed by 10 
passes through a Teflon-glass homogenizer rotating 
at 1000 rpm. The homogenate was centrifuged at 
1000 g for 10 min, and the supernatant was 
centrifuged at 360,000 g for 40 min at 4°C. The 
pellet was resuspended in isolation buffer. Protein 
contents were determined using the Bradford 
protein assay (microBradford, Bio Rad 
Laboratories, Hercules, CA).  
Exosome preparation. Urinary exosomes were 
preparated as previoulsy described in details by 
Pitsikun et al. (16). Briefly, urines from TK knock-
out and WT mice housed in metabolic cages were 
collected daily in tubes containing a protease 
inhibitor mixture (in g/ml: 1 leupeptin, and 100 
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AEBSF) and sodium azide. A pool of 75-90 ml 
urine per group were used. Urine samples were 
extensively vortexed immediately after they 
thawed. The urines were centrifuged at 17,000 g for 
15 min at 4°C to remove whole cells, large 
membrane fractions and other debris. Supernatants 
were centrifuged at 200,000 g for 1 hour at 4°C to 
obtain a low-density membrane pellet. The 
exosome-associated proteins isolated from the 
pooled urine samples were suspended in isolation 
solution (250 mM sucrose, 10 mM ethanolamine, 
pH 7.6, containing protease inhibitors in g/ml: 1 
leupeptin, and 100 AEBSF). Protein contents were 
determined using the Bradford protein assay (Bio 
Rad Laboratories, Hercules, CA). Values were 
normalized for urine creatinine to ensure adequate 
protein loading in western blot experiments, i.e., to 
allow comparison of the abundance in exosome 
associated proteins from urine samples of the same 
time for each group, as proposed by others (17). 
Antibodies. Rabbit polyclonal antibodies to NHE3 
and NKCC2 have been characterized previously 
(18). Rabbit polyclonal antibodies to NaPi-2a was 
given by J. Biber (Zürich University, Switzerland) 
and has been characterized previously (19). 
Chicken anti Na
+
,K
+
-ATPase polyclonal antibody 
was purchased from Chemicon International Inc. 
(Temecula, CA, USA). Rabbit polyclonal 
antibodies directed to -ENaC (amino acids 46–
68), ß-ENaC (amino acids 617–638), and -ENaC 
(amino acids 629–650), were raised by G. 
Deschenes using exactly same peptides have been 
originally described by Masilamani et al. (20). All 
these antibodies have been described and 
characterized previously (21). When necessary, 
new batches of antibodies were tested in 
preliminary experiments to verify that the 
specificity was identical to that of the antibodies 
from the original batch (not shown). 
Immunoblot analyses. Membrane proteins were 
solubilized in SDS-loading buffer (62.5 mM Tris 
HCl, pH 6.8, 2% SDS, 100 mM dithiotreitol, 10% 
glycerol and bromophenol blue), incubated at room 
temperature for 30 min. Electrophoresis was 
initially performed for all samples on 7.5% 
polyacrylamide minigels (XCell SureLock Mini-
cell, Invitrogen Life Technologies), which were 
stained with Coomassie blue to provide quantitative 
assessment of loading, as previously described (14). 
For immunoblotting, proteins were transferred 
electrophoretically (XCell II Blot Module, 
Invitrogen Life Technologies) for 1.5 h at 4°C from 
unstained gels to nitrocellulose membranes 
(Amersham, Arlington Heights, IL) and then 
stained with 0.5% Ponceau S in acetic acid to check 
uniformity of protein transfer onto the 
nitrocellulose membrane. Membranes were first 
incubated in 5% nonfat dry milk in phosphate-
buffered saline, pH 7.4 (PBS) for
 
1 h at room 
temperature to block nonspecific binding of 
antibody, followed by overnight at 4°C with the 
primary antibody (anti-NHE3 1:1000; anti-NaPi2 
1:20000; anti-NCC 1:50000; anti-NKCC2 1:5000; 
anti--ENaC 1:3000; anti-ß-ENaC 1:20000; anti--
ENaC 1:2000 ; anti-Na
+
/K
+
ATPase 1:20000) in 
PBS containing 1% nonfat dry milk.  After four 5 
min washes in PBS containing 0.1% Tween-20, 
membranes were incubated with 1:10000 dilution 
of goat anti-rabbit IgG conjugated to horseradish 
peroxidase (Bio-Rad, Hercules, CA) or peroxidase-
conjugated affiniPure donkey anti-chicken IgY 
(Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA, USA) in PBS containing 5% nonfat dry 
milk for 2 hours at room temperature. Blots were 
washed as above, and luminol-enhanced
 
chemiluminescence (ECL, Perkin Elmer Life 
Science Products, Inc. Boston, MA) was used to 
visualize
 
bound antibodies before exposure to 
Hyperfilm ECL (Amersham, Arlington Heights, 
IL). The autoradiography was digitized with use of 
a laser scanner (Epson Perfection 1650, Epson), and 
quantification of each band was performed by 
densitometry using NIH Image software. 
Densitometric values were normalized to the mean 
for the control group that was defined as 100% and 
results were expressed as mean ± S.E.  
 For deglycosylation experiments, protein 
samples were incubated for 1 hour at 37 °C with or 
without peptide N-glycosidase F (PNGase F) 
according to the manufacturer's instructions (Roche 
Diagnostics, Mannheim, Germany), and processed 
for immunoblotting as described above. 
 To assess whether or not TK promotes -
ENaC cleavage in vitro, renal cortical membrane 
fractions from TK
-/-
 mice, were prepared as 
described above exept that proteases inhibitors 
were omitted. To compare their ability to promote 
-ENaC cleavage, urines from TK-/- and WT mice 
were first desalted against Tris buffer (0.2 M, pH 
8.2) in a centricon column (Centricon-10, cut-off 10 
kDa, Millipore). Final volume of the desalted urine 
was 1/3 of the initial volume of urine introduced in 
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the column. Membrane fractions were incubated 
with desalted urines for 1.5 h at 37°C, or with 
purified TK from porcine pancreas (Sigma-Aldrich, 
Lyon, France) before SDS-PAGE and 
immunoblotting with anti -ENaC antibody as 
described above.  
Measurement of alveolar fluid clearance in 
mouse. Sodium-driven alveolar fluid clearance 
(AFC) was measured in vivo using an in situ non-
ventilated mouse lung model, as previously 
described (22,23). This model has been shown to 
give AFC values similar to those obtained with the 
ventilated mouse model over a 15-min period. 
Briefly, male or female wild type or TK
-/-
 mice aged 
2-5 months were euthanized with intraperitoneal 
pentobarbital (250 mg/kg) and maintained at 37-
38°C using a heating pad, an infrared lamp and an 
intraabdominal monitoting thermistor. A 20-gauge 
venous catheter was inserted in the trachea through 
a tracheotomy and tightly fixed. The lungs were 
inflated with 100% O2 at 7 cm H2O continuous 
positive airway pressure throughout the experiment. 
Then, 10 ml/kg of instillate was delivered to the 
lungs over 30 s through the tracheal catheter. The 
instillate consisted of Ringer’s lactate (pH 7.4) 
adjusted to 325 mosmol/kg H2O with NaCl, 
containing 5% bovine serum albumin (BSA) and 
0.1 Ci/ml 125I-albumin (Cis Bio International, Gif-
sur Yvette, France) as a labelled alveolar fluid 
volume tracer. An alveolar fluid sample (50-100 l) 
was aspirated 1 min after instillation and at the end 
of experiment (15 min later). The aspirates were 
centrifuged at 3,000 g for 10 min, and the 
radioactivity in supernatants was counted in 
duplicate. Alveolar fluid clearance (percentage 
fluid absorption at 15 min) was calculated from the 
increase in alveolar fluid albumin as follows : AFC 
(%) = (Cf – Ci) / Cf  x 100, where Ci and Cf 
represent the initial and final concentrations of 
125
I-
albumin in the aspirate at 1 and 15 min 
respectively, as assessed by radioactivity 
measurements. In some experiments, amiloride (1 
mM) was added to the instillate and AFC was 
measured at 15 min as described above. ENaC-
mediated AFC represents the difference between 
total AFC values (in the absence of amiloride) and 
amiloride-insensitive AFC values (in the presence 
of amiloride). Results are presented as means ± SE. 
One-way variance analyses were performed and, 
when allowed by the F value, results were 
compared by the modified least significant 
difference (Statview software). P<0.05 was 
considered significant. 
Measurement of rectal transepithelial potential 
difference. The mice were anesthetized with an 
intra-peritoneal injection of Ketalar (Park-Davis, 
Courbevoie, France) 75g/g body weight and 
Rompun (Bayer, Puteaux, France) 2.3g/g body 
weight and placed on a heated table. A winged 
needle filled with isotonic saline was placed in the 
subcutaneous tissue of the back. A double-barreled 
pipette was prepared from borosilicate glass 
capillaries (1.0 mm OD/0.5 mm ID, Hilgerberg, 
Malsfeld, Germany)  and pulled to a ~0.2 mm tip 
diameter. The first barrel was filled with isotonic 
saline buffered with 10 mM Na
+
-HEPES (pH 7.2), 
and the second barrel with the same solution 
containing 25 µM amiloride. The tip of the double-
barreled pipette was placed in the rectum about 3-5 
mm from the skin margin. The electrical potential 
difference was measured between the first barrel 
and the subcutaneous needle, both connected to 
Ag/AgCl electrodes by means of plastic tubes filled 
with 3 M KCl in 2% agar. The rectal PD was 
monitored continuously by a VCC600 electrometer 
(Physiologic Instruments, San Diego, CA) 
connected to a chart-paper recorder. After 
stabilization of the rectal PD (about 1 min), 0.05 ml 
of saline solution was injected through the first 
barrel as a control manoeuver and the PD  was 
recorded for another 30-second period. A similar 
volume of saline solution containing 25 M 
amiloride was injected through the second barrel of 
the pipette and the PD was recorded for another 1 
minute. The amiloride-sensitive PD was calculated 
as the difference between the PD recorded before 
and after addition of amiloride. 
 Evaluation of apical Na
+
 entry in isolated CCD 
microperfused in vitro. Experiments were 
performed as previously described by others (24). 
Briefly, CCD segments were dissected from 
C57Bl/6 mouse, mounted on concentric pipettes 
and perfused in vitro. During intracellular pH 
measurement experiments, the average tubule 
length exposed to bath fluid was limited to 300 – 
350 m in order to prevent motion of the tubule. 
The dissection and initial luminal and peritubular 
solutions were composed of (in mM) 25 NaCl, 119 
N-methyl-D-glucamine gluconate, 1.2 MgSO4, 2 
K2HPO4, 2 CaCl2, 5 D-glucose, and 10 HEPES 
and was adjusted to a pH of 7.4. Tubules were 
bathed and perfused with this same solution. For 
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the experiments, CCDs were bathed in a modified 
solution in which NaCl was isosmotically replaced 
with N-methyl-D-glucamine gluconate to achieve 
an NaCl concentration of 0 mmol/L and containing 
the Na ionophore monensin (10
-5
 M). This 
maneuver effectively eliminated the basolateral 
membrane as a barrier for Na movement. Under 
these conditions, Na entry across the apical 
membrane is the only means of altering [Na]i. 
 To identify principal and intercalated cells, 
we labeled intercalated cells by adding fluorescein-
labeled peanut lectin (PNA,Vector Labs) to the 
luminal perfusate for 5 minutes and observed which 
cells were fluorescent with excitation and emission 
wavelengths of 440 and 530 nm, respectively. [Na]i 
in CCD cells was assesed with imaging-based, dual 
excitation-wavelength fluorescence microscopy 
with use of the fluorescent probe sodium-binding 
benzofuran isophthalate (SBFI, Molecular probes). 
Tubules were loaded with 2x10
-5 
M of the 
acetoxymethyl ester of SBFI added to the luminal 
perfusate. Intracellular dye was excited 
alternatively at 340 and 380 nm with a 100-watt 
Xenon lamp and a computer-controlled chopper 
assembly. Emitted light was collected through a 
dichroïc mirror, passed through a 510 nm filter and 
focussed onto a CCD camera (ICCD 2525F, 
Videoscope International, VA) connected to a 
computer. The measured light intensities were 
digitized with 8-bit precision (256 grey level scale) 
for further analysis. For each tubule, 2 to 4 
principal cells were analyzed : the mean grey level 
for each excitation wavelength was calculated with 
the Starwise Fluo software (Imstar, Paris, France). 
SBFI fluorescence ratios (340/380 nm) were used 
as an estimator of [Na]i values. 
 
 
 RESULTS 
 
Evidence for decreased sodium channel activity in 
the kidney and the distal colon. TK is secreted into 
the luminal fluid of the distal part of the ASDN, 
where ENaC is believed to be the limiting step for 
Na
+
 reabsorption, and an strong inverse relationship 
has been described between the amount of TK 
excreted in the urine and blood pressure in humans 
(3,4). We speculated that TK might be a factor 
regulating ENaC activity. To test renal ENaC 
function in vivo, we first tested the effects 
amiloride on urinary sodium excretion in TK
-/-
 
mice. Fig 1A shows that a single dose of amiloride 
(subcutaneous injection of 1.45 mg . kg bw
-1
) 
significantly increased urinary Na
+
 excretion during 
the next two hours following the injection in WT 
mice whereas the effect of amiloride on Na
+
 
excretion was blunted in TK
-/-
 mice. This result, 
indicated that renal ENaC activity was decreased in 
mice lacking TK production.  
 The distal colon also expresses all three 
ENaC subunits, mRNA for TK has been found to 
be highly expressed in the colon, and abundant TK 
activity is measurable in the feces (6). Thus, we 
hypothesized that if TK activates ENaC, this effect 
may be detectable in the distal colon. We tested this 
hypothesis in vivo by measuring amiloride-sensitive 
transepithelial rectal potential difference, an index 
of ENaC-mediated Na
+
 transport, in WT and TK
-/-
 
mice. As shown in Figure 1B, the amiloride-
sensitive rectal potential difference was 
significantly decreased in TK
-/-
 mice compared to 
WT mice, indicating that as in the kidney, TK is an 
activating factor of ENaC in the distal colon. 
 Table 1 shows that TK
-/-
 mice were able to 
maintain normal Na
+
 balance with no evidence for 
extracellular fluid volume depletion. Moreover, the 
animals were pair fed, and hence identical urinary 
excretion of Na
+
 and Cl
-
 (see Table 1) indicated that 
they were able to achieve a steady state. Thus, 
although the TK
-/-
 mice are able to excrete the full 
amount of NaCl taken in the diet and maintain a 
steady state, they do so with a concomitant decrease 
in amiloride-sensitive (ENaC-mediated) sodium 
absorption, implying that amiloride-independent 
Na
+
 absorption, presumably upstream from the 
collecting duct system, is increased.  
 
Luminal TK activates ENaC in principal cells of 
cortical collecting duct isolated and microperfused 
in vitro. Our preceding experiments indicate that 
TK
-/-
 mice have a decreased in ENaC-mediated Na
+
 
transport in kidney. Therefore, to confirm more 
directly that TK is able to activate ENaC, we next 
examined the effects of extracellular (luminal) TK 
on ENaC in CCDs isolated and microperfused in 
vitro. Intercalated cells were identified by adding 
fluorescein-labeled peanut lectin to the luminal 
perfusate for 5 minutes and observed which cells 
were fluorescent. [Na]i in principal cells was then 
assessed with use of the fluorescent probe sodium-
binding benzofuran isophthalate (SBFI), as 
previously described (24). ENaC is the limiting step 
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for Na entry into principal cells, therefore, if TK 
activates ENaC, [Na]i is expected to increase when 
TK is perfused to the luminal surface of the CCD. 
Accordingly, Figure 2 shows that TK was able to 
increase significantly the ratio of F340/F380 SBFI 
fluorescence, which reflects an increase in [Na
+
]i, 
whereas no change was observed in CCD perfused 
with vehicle only. Moreover, TK-dependent 
increase in [Na
+
]i was prevented when the tubules 
were pre-treated with 10
-5
M amiloride, indicating 
that the effect of TK on [Na]i is a consequence of  
ENaC activation. 
 
ENaC processing is impaired in TK-/- mice. 
Because TK is a serine protease, it is possible that 
TK-induced ENaC activation occurs through ENaC 
proteolysis. Thus, we next examined ENaC-related 
polypeptides by western blot. As shown in Figure 
3, antibodies to the C-terminus of -ENaC detect a 
major band at 85 kDa, as well as a minor 80 kDa 
band. An additional broad band centered around 70 
kDa was detected in WT mice but not in TK
-/-
 mice. 
This 70 kDa band is believed to originate from the 
proteolytic cleavage of the N-terminal end of the 85 
kDa form and to be related to aldosterone-
dependent activation of ENaC (20). When renal 
samples from WT mice were deglycosylated with 
PNGase and immunoblotted using anti-ENaC, the 
85-kDa band shifted to 72 kDa and the broad 70 
kDa band shifted to a major 50-kDa band and a 
weaker 60-kDa band (Fig 4A). No change in 
protein abundance of neither the - and ß-subunits 
of ENaC nor other Na
+
 transporter expressed along 
the nephron was detected (Fig 3, Table 2).  
 
TK is able to promote the cleavage of -ENaC in 
vitro. If TK is important for the activation of ENaC 
via its proteolytic properties on -ENaC subunit, 
TK should be able to promote the cleavage of this 
protein in vitro. Renal membrane fractions from 
TK
-/-
 mice, prepared in the absence of protease 
inhibitors to avoid in vitro inactivation of TK, were 
incubated with porcine pancreatic TK at 100 or 30 
g/ml, or with vehicle alone for 15 minutes at 37 
°C. Figure 5A shows that only the 85 kDa band is 
detected on renal membrane fractions from TK
-/-
 
mice exposed to the vehicle and that the 70 kDa 
band of the -ENaC appeared in samples incubated 
with both concentrations of TK. Densitometric 
analyses were performed to quantify the appearance 
of the kallikrein induced 70 kDa -EnaC (Figure 
5B). Band densities of the 70 kDa band of 4 
independent immunoblots were normalized to total 
densities of the -ENaC. The 70 kDa band was 
significantly increased by TK at both 
concentrations over control. At the highest 
concentration of TK, the total densities of -ENaC 
was significantly decreased presumably due to 
nonspecific protein degradation.  
 Porcine pancreatic TK is extracted from 
pancreas and might therefore contain small amount 
of other protease, particularly trypsin, which is 
known to activate ENaC. Thus, in a second set of 
experiments, desalted urines collected from WT 
and TK
-/-
 mice and renal membrane fraction from 
TK
-/-
 mice (i.e. naturally devoid of detectable 70 
kDa form of -ENaC, see Fig. 3) were used. As 
shown in Figure 5C, when renal membrane 
fractions prepared from a TK
-/-
 mouse were 
incubated with desalted urines from either WT or 
TK
-/-
 mice, the 70 kDa band of -ENaC appeared in 
samples incubated with urine from WT mice but 
not with urine from TK
-/-
 mice, indicating that 
urinary kallikrein favors cleavage of -ENaC in 
vitro. No cleaved band appeared in untreated 
samples kept in parallel over the period of the 
experiment indicating that the 70 kDa band is not 
the result of nonspecific degradation. 
 
Impaired ENaC processing leads to decreased 
abundance in urinary exosomes. Study of urinary 
exosome-associated proteins provides a means for 
analysis of changes in apical protein expression of 
renal tubular cells (16). We looked at changes in 
the excretion of the three subunits of ENaC in three 
independent preparations of urinary exosomes from 
WT and TK
-/-
 mice by immunoblotting using anti-N 
terminus -ENaC antibody, and anti-C terminus ß- 
or -ENaC antibodies. Figure 6 shows 
representative immunoblots. Only the ß- and - 
subunits of ENaC were detectable in the urinary 
exosome preparations from WT mice. In human 
exosome preparations, all three subunits were 
detected (16). Regarding -ENaC, note that, as 
previously reported (16) in human exosomes, only 
the 70 kDa form of the -ENaC was detectable in 
mouse exosomes, suggesting that this is the only 
molecular form of -ENaC present at the apical 
surface of the collecting duct cells. As expected 
from the results shown in Figure 3, the -subunit of 
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ENaC was dramatically decreased in urinary 
exosome preparation from TK
-/-
 mice (25 ± 2 % of 
control, p<0.001). We also observed a marked 
decrease in -ENaC protein abundance (24 ± 6 % 
of control, p<0.01). As in WT mice, -ENaC was 
undetectable in urinary exosomes from TK
-/-
 mice. 
Importantly, the protein abundance of NCC, 
assessed on same preparations, was not altered (102 
± 34 % of control, p=0,96), indicating that the 
decrease in - and -ENaC subunits is specific and 
not due to incomplete sampling of urine.  
 
Semiquantitative immunoblots for -ENaC in 
mutant mice lacking kinin-B2 receptor (B2
-/-
). To 
rule out the possibility that the disappearance of the 
renal 70 kDa form of -ENaC in TK-/- mice might 
be the consequence of the absence of locally-
generated bradykinin rather than a direct effect of 
TK disruption on ENaC proteolysis, we next 
performed immunoblots for -ENaC on cortical 
membrane fractions obtained from WT and B2
-/- 
mice (Figure 7). The combined densities of the 85 
kDa and 70 kDa bands were unchanged in B2
-/-  
mice (100 ± 3 % vs. 100% ± 6 % in TK
-/-
 and WT 
mice, respectively). In contrast to what was 
observed in TK
-/-
 mice (see Figure 1A), the 
abundance of the 70 kDa form of -ENaC was 
increased in B2
-/-  
mice (159 ± 23 % vs. 100 ± 6 % 
in B2
-/-
 and WT mice, respectively, p = 0.03). There 
was no significant difference in the abundance of 
the 85 kDa form of -ENaC (84  ± 13 % compared 
with wild type, 100 ± 6%). 
 
Evidence for unchanged sodium channel activity 
in lung. In contrast to the kidney and the colon, 
lung alveolar epithelial cells express ENaC but do 
not secrete TK, therefore we hypothesized that 
ENaC processing in the lung is TK-independent. 
Fig 8A shows that amiloride-sensitive alveolar fluid 
clearance, used as an estimate of ENaC-mediated 
Na
+
 transport (23), was not significantly different in 
TK
-/-
 mice compared with WT mice. Figure 8B 
shows that the biochemical profile of -ENaC in the 
lung appears as two major bands, one at 85 kDa 
similar to that one observed in the kidney and 
another one resolving at 75-70 kDa. These bands 
were no longer detected when anti -ENaC was 
preincubated with the peptide antigen (data not 
shown). There was no significant difference in the 
abundance of the 85 kDa -ENaC (102 ± 5 % vs. 
100  ± 12%, in TK
-/-
 and WT mice respectively) 
and of the 75-70 kDa -ENaC (103 ± 6 % vs. 100  ± 
8%, in TK
-/-
 and WT mice respectively). 
Deglycosylation with PNGase gave a pattern 
similar to that one seen in renal samples from WT 
mice except that the size of the major fragment was 
60 kDa (data not shown).  
 
Adaptation of TK deficient mice to dietary Na
+
 
restriction and response to aldosterone infusion  
As stated above, TK
-/-
 mice showed no evidence for 
altered blood volume. However, it is not unusual 
that altered sodium transport in transgenic mice 
leads to limited phenotypes. Despite decreased 
ENaC activity in the absence of TK production, 
TK
-/-
 mice were able to adapt normally in response 
to acute dietary sodium restriction. Both genotypes 
significantly decreased urinary Na
+
 excretion after 
Na
+
 restriction. No significant difference were 
observed among groups (Data not shown). In 
addition, urinary aldosterone levels increased 
similarly in TK
-/-
 (11.96 ± 3.35 nmol/mmol 
creatinine) and WT mice (12.21 ± 1.64 nmol/mmol 
creatinine) after 3 days Na
+
 depletion. This result 
indicated that in response to Na
+
 restriction, TK
-/-
 
mice were able restore normal ENaC function. In 
WT animals undergoing sodium restriction, the 
broad 70 kDa band was easily detected on 
immunoblots for -ENaC (Fig. 9A), consistent with 
previous observations (20,25,26). In TK
-/-
 mice, 
sodium depletion was associated with the 
appearance of polypeptides of molecular weights 
ranging from 75 to 70 kDa (compare WT and TK
-/-
 
lanes in Fig. 7A). Same results were observed in 
mice treated with aldosterone (Fig 9B). 
Deglycosylation with PNGase of aldosterone 
infused WT and TK
-/-
 mice gave a similar pattern 
except that the size of the major fragments was 50 
kDa and 60 kDa for WT and TK
-/-
 mice, 
respectively (Fig. 4B).These sets of experiments 
demonstrate that in the nominal absence of TK 
ENaC can still be processed and activated by other 
serine proteases, presumably from the CAP family. 
 
 
DISCUSSION 
 
 The present study demonstrates that TK is a 
physiological activator of ENaC. This activation is 
associated with the proteolytic cleavage of the full 
length 85 kDa form of -ENaC subunit within its 
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 9, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
    8
extracellular domain to produce a truncated peptide 
of 70 kDa corresponding to the C-terminal end of 
the entire protein. This demonstration is based on 
several observations: 1) TK
-/-
 mice have decreased 
ENaC activity in the kidney and also the distal 
colon, two organs that exhibit ENaC-mediated Na
+
 
transport and abundantly produce TK; 2) TK 
increased ENaC-dependent Na
+
 entry when applied 
to the luminal surface of CCDs isolated and 
microperfused in vitro; 3) At steady state, TK 
deficient mice have a marked decrease in the 
protein abundance of the truncated -ENaC peptide 
in the kidney and in urinary exosomes, a 
preparation that reflects the pool of protein apically 
expressed in renal tubular cells ; 4) TK is able to 
promote the cleavage of -ENaC in vitro; 5) In the 
lung alveolae, an organ devoid of TK expression, 
TK disruption did not impair ENaC processing and 
activity. 
ENaC is a hetero-multimeric protein 
composed or three related subunits ,  and . All 
subunits have an intracytoplasmic N- and C-
terminus, and two membrane spanning domains 
connected by a large extra-cellular loop. ENaC 
activity can be regulated by changes in membrane 
protein abundance of the channel or by changes in 
single-channel open probability. Recently, it has 
been proposed that proteolytic processing of - and 
- subunits by several serine proteases increases 
ENaC open probability (11,12,27-29). Conversely, 
non-processed ENaC have been demonstrated to be 
almost inactive when expressed in cell cultures. In 
this model, extracellular trypsin stimulates ENaC, 
whereas extracellular serine protease inhibitors, 
such as aprotinin and bikunin, have been shown to 
decrease ENaC activity (12,29-32). However, 
despite this evidence that proteolytic processing of 
ENaC stimulates channel activity, the molecular 
identity of the protease that could mediate this 
effect in vivo is still uncertain. As stated above, 
trypsin can activate ENaC. Elastase, a serine 
protease naturally produced by neutrophil 
polynuclear has also been proposed to activate 
ENaC in vivo during pulmonary inflammatory 
states (28). More recently, direct evidence for 
exogenous cleavage of -ENaC and activation at the 
cell surface by elastase in Xenopus oocytes 
experiments has been provided by Harris et al. (33). 
However, trypsin and elastase are not very good 
candidates for in vivo physiological regulation of 
ENaC in the kidney because they are normally not 
expressed and secreted in this organ. Furin, a 
proprotein convertase involved in many 
physiological or pathophysiological processes, 
including activation of hormones and growth 
factors to bacterial toxins and viral glycoproteins 
processing is also able to cleave and activate ENaC 
in vitro (11,34). A family of serine proteases has 
been identified that could cleave and activate 
ENaC, including CAP1, CAP2, CAP3, and 
TMPRSS3 (12,23,35-38). Importantly, it has been 
shown, that aldosterone modifies urinary excretion 
of prostasin, the human ortholog of CAP1 (39), 
suggesting that prostasin could be the link between 
aldosterone and proteolytic activation of ENaC in 
the kidney. Unfortunately, gene disruption of furin 
or CAP1 are lethal rendering difficult direct 
assessment of their physiological role in ENaC 
regulation (40,41). It is also possible that 
proteolytic activation of ENaC involves more than 
one effector. This is supported by the observation 
that the proteolytic processing of -ENaC by furin 
seems to occur intracellularly, whereas trypsin, 
elastase or the CAPs are believed to act 
extracellularly. Moreover, it has recently been 
demonstrated that furin or prostasin are able to 
produce different polypeptides from -ENaC (42).  
Here we report that a serine protease 
promotes -ENaC cleavage in vivo and in vitro (see 
figure 1A and 5) and that this proteolytic 
modification correlates with the activation of 
ENaC. Active TK excretion is positively correlated 
with mineralocorticoid levels (43,44). Interestingly, 
it has also been shown that the protein abundance 
of the 70 kDa form of -ENaC (the truncated form 
which disappears in TK
-/-
 mice) also correlates with 
circulating aldosterone level (20). Therefore, it is 
tempting to conclude that TK is responsible for part 
of the aldosterone-dependent processing/activation 
of the channel. However, it is important to state that 
it is not possible to conclude that TK is directly 
responsible for the cleavage itself (i.e. that TK 
physically interacts with and cleaves -ENaC). 
Indeed, in our in vitro experiments we used 
membrane fractions from TK
-/-
 mice. This material 
does not contain TK but it probably expresses 
several other proteases, particularly several 
members of the CAP family that are membrane-
bound. Therefore, it is possible that the action of 
TK on -ENaC is indirect. For example, it is 
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conceivable that TK activates a CAP-dependent 
signaling cascade leading ultimately to ENaC 
processing as proposed by B. Rossier recently (45).  
 Since the TK
-/-
 mice did not exhibit gross 
alterations in sodium balance or extracellular fluid 
regulation, it could be also argued that TK does not 
play a substantial physiological role under normal 
circumstances. However, since regulation of Na
+
 
reabsorption in the kidney is critical for 
extracellular fluid volume and blood pressure 
regulation, the mechanisms for regulation of Na
+
 
reabsorption are highly highly redundant. That is, 
animals can generally compensate for defective 
regulation at one renal tubule segment by 
increasing absorption at another renal tubule 
segment, lowering blood pressure or reducing GFR 
to come into Na
+
 balance. Thus, in the present 
study, altered regulation at the level of ENaC is 
likely to be compensated for.  One example of this 
is seen in mice in which the thiazide-sensitive NaCl 
cotransporter, responsible for 5-10 percent of 
sodium reabsorption under normal circumstance 
(46). These mice appear healthy and are normal 
with respect to plasma electrolyte concentrations, 
serum aldosterone levels, and blood pressure. 
Moreover, NCC
-/-
 mice retain Na
+
 as well as wild-
type mice when fed a Na
+
-depleted diet (47).  In 
contrast, these mice show abnormalities in 
homeostasis of other ions including Ca
++
 (47) and 
K
+ 
 (48). One other possible explanation is that the 
TK gene inactivation does not only disrupt TK 
production but also impairs local bradykinin 
production. Inhibition of bradykinin production is 
expected to limit natriuresis while TK disruption is 
expected to limit ENaC activation. Therefore, the 
phenotype arising from both effects might be very 
limited. Finally, in the absence of TK, some 
proteolytic activation of the channel can still occur 
and produce several different polypeptides that are 
presumably active (see Fig 9). The role of furin or 
CAPs in this compensation requires further 
investigation. For example, CAP could permit the 
cleavage of the 85-kDa -ENaC form and therefore 
activation of ENaC in TK
-/-
 mice with elevated 
circulating aldosterone. Based on the size of the 
fragments obtained following deglycosylation of 
the cleaved form of -ENaC (60 and 50 kDa) which 
are recognized by the anti -ENaC antibody 
directed against the COOH terminus of -ENaC, the 
proteolytic cleavage seems to occur at two different 
sites in the early portion of the extracellular loop of 
the -ENaC, which are approximately one hundred 
amino acid apart. Deglycosylation of renal samples 
from either control, or aldosterone treated WT mice 
showed that the 70 kDa protein shifted to a major 
50 kDa protein (figure 2). Deglycosylation of 
kidney samples from aldosterone infused TK
-/-
 mice 
showed that the broad 75-70 kDa protein shifted to 
a major 60-kDa protein and a weaker 50-kDa 
protein (figure 2). Membrane samples from lung, an 
organ not expressing TK (6) showed a similar 
pattern following deglycosylation. These results 
suggest that the renal 70-kDa -ENaC could result 
from the proteolytic cleavage of the 85-kDa -
ENaC form by the TK itself (or at least dependent 
on TK), whereas the 75-70 kDa broad protein seen 
in kidney sample from TK
-/-
 mice with elevated 
circulating aldosterone or lung sample from either 
WT or TK
-/-
 mice could result from the proteolytic 
cleavage of the 85-kDa -ENaC by another serine 
protease such as CAPs or furin. We also report that 
ENaC is functionally normal in  lung alveoli of TK
-
/-
 mice, confirming that ENaC in the lung can be 
processed by another protease than TK. These 
observations highlight the fact that TK-dependent 
activation of ENaC may be tissue specific. 
 In conclusion, this study identified an 
antinatriuretic effect of TK, and  we propose that 
TK is a physiological activator of ENaC that 
belongs to a complex cascade of protease that are 
required for full stimulation of Na transport within 
the ASDN. The data from our model of TK 
inactivation strongly suggest that the decrease in 
renal TK production that has been found repeatedly 
to be associated with high blood pressure in 
humans is rather a consequence than a cause of this 
disease. 
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FIGURE LEGENDS 
 
Figure 1 : Effects of TK disruption on ENaC function in the kidney and colon. A) Effect of amiloride 
injection on urinary Na
+
 excretion in TK
-/-
 and WT mice. Mice kept under normal Na
+
 diet (0.3 % Na
+
 in 
food) were subcutaneously injected with amiloride (1.45 mg/kg body weight). Urines from TK
-/-
 (filled 
square) and WT mice (filled triangle) were collected over two days from 9 to 11 am, 11 am to 2 pm, 2 to 6 
pm and 6 pm to 9 am ; amiloride was injected at 9 am the second day. UNa
+
/Ucreatinine represents the 
urinary Na
+
 concentration in mM normalized to the urinary concentration of creatinine in mM. Values are 
the means ± SE from 5 to 9 determinations in each group. *P<0.05, **P<0.01 vs time controls ; # P< 0.01 
vs TK
-/- 
mice. B) Diurnal variations in amiloride-sensitive rectal potential difference (PD) in TK knockout 
mice. In vivo measurements of amiloride-sensitive rectal potential difference (PD) in TK
-/-
 (white bars) and 
WT (black bars) mice were performed in the morning (10~12 am) and afternoon (4~6 pm). The data show a 
significant decrease in amiloride-sensitive sodium transport in the colon of TK knock-out  mice ( n= 4 to 6 
mice per group). *P <0.05.  
 
Figure 2 : Time course of SBFI fluorescence, an estimate of [Na
+
]i, in principal cells of CCDs isolated 
and microperfused in vitro. CCDs isolated from WT mice were perfused with either TK (10g/ml) in the 
absence (filled circles) or the presence of 10
-5
M amiloride (asterisk), or perfused with vehicle alone (open 
circles). After 10 min of TK perfusion, SBFI fluorescence increased significantly in TK treated tubules 
(p<0.05 vs. controls), reflecting a rise in [Na
+
]i, whereas no change occurred in CCD perfused with vehicle. 
Moreover, 10
-5
M amiloride in the luminal fluid prevented the TK-induced rise in [Na
+
]i demonstrating that 
this effect reflects ENaC activation by TK.  (n=3 in each group) 
 
Figure 3 : Immunoblot of renal cortex membrane fractions from TK
-/-
 and WT mice with antibodies to 
-, -, and -subunit of ENaC. The 70kDa -ENaC polypeptides were undetectable, whereas -, and -
subunits-related polypeptides were unchanged. Each lane was loaded with a protein sample from a different 
mouse. Equal loading was confirmed by parallel Coomassie stained gels.  
 
Figure 4 : Glycosylation pattern of -ENaC protein in mouse renal cortex. Protein samples (A,  
membrane fractions from TK
-/-
 and WT mice under basal conditions and aldosterone infused TK
-/-
 and WT 
mice renal cortex ; B, membrane fractions from aldosterone infused TK
-/-
 and WT mice renal cortex) were 
incubated with or without N-glycosydase F (PNGase F) for 1 hour at 37°C before SDS-PAGE and 
immunoblotting for -ENaC 
 
Figure 5 : Tissue Kallikrein promotes -ENaC cleavage in vitro. Panel A: Renal membrane fractions 
from TK
-/-
 mice were incubated with TK and apparition of the 70 kDa form of -ENaC was studied by 
immunoblotting. Membrane proteins were mixed with either 0, 30 or 100g/ml of TK purified from porcine 
pancreas and incubated for 15 min. at 37°C. Panel B: Densitometric analyses of data showing the 
appearance of the 70 kDa form following treatment with TK. Panel C: Renal membrane fractions from TK
-/-
 
mice were incubated with desalted and concentrated urines from WT or TK
-/-
 mice for 1.5 hours at 37°C. 
The apparition of the 70 kDa form of -ENaC was studied by immunoblotting. 
 
Figure 6 : Abundance of ENaC subunits and NCC by immunoblotting in urinary exosomes from TK 
knockout and WT mice normalized to urine creatinine, and kidney cortex from wild type mouse. 
Lanes, from left to right, were loaded with protein samples from wild type mouse kidney cortex (lane 1), 
urinary exosomes from wild type mice (lane 2) and urinary exosomes from TK knockout mice (lane 3). 
Immunoblots are representative of three independent experiments.  
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Figure 7 : Abundance of -ENaC protein by immunoblotting in membrane fractions from kidney 
cortex of B2
-/-
 and WT mice. Panel A: Immunoblot of renal cortex membrane fractions from TK
-/-
 and WT 
mice. Each lane was loaded with a protein sample from a different mouse. Equal loading was confirmed by 
parallel Coomassie stained gels. Panel B: Densitometric analyses of immunoblots showing that the 
abundance of the 70 kDa form is significantly increased in B2 receptor knockout mice. *: P<0.05 versus 
WT mice. 
 
Figure 8 : Analyses of -ENaC polypeptides and of ENaC function in the lung. Panel A, Effect of TK 
knock-out on sodium-driven alveolar fluid clearance in mice. Sodium-driven alveolar fluid clearance (AFC) 
was measured over a 15 min-period in WT and TK
-/-
 mice aged 2-5 months at 37°C using an in situ non 
ventilated model in which the airspace was instilled with an isoosmolar Ringer’s lactate solution containing 
125
I-albumin as a volume marker, as described in Methods. Experiments were performed either in the 
absence (Total AFC, black bars) or in the presence of 1mM amiloride (Amil, white bars) in the instillate. 
Results are expressed as percentage fluid absorption at 15 min, and represent means ± SE of 8-9 mice in 
each group for total AFC experiments, and 4 mice in each group for amiloride experiments. Panel B : 
Abundance of -ENaC protein by immunoblotting in membrane fractions from lung of TK-/- and WT mice. 
Each lane was loaded with a protein sample from a different mouse. Equal loading was confirmed by 
parallel Coomassie stained gels. No significant differences in the abundance levels of the 85 kDa band and 
the 75-70 kDa band were observed between WT and TK
-/-
 mice. *: significantly different from 
corresponding total AFC value (P<0.05). NS: not significantly different. 
 
Figure 9 : Effect of TK knock-out on -ENaC protein in mice undergoing dietary Na+ restriction or chronic 
aldosterone infusion. Immunoblots for -ENaC of membrane fractions from kidney cortex of TK knockout 
and wild type mice under Na
+
 restricted diet (A) or following chronic aldosterone administration (B). Each 
lane was loaded with a protein sample from a different mouse. Equal loading was confirmed by parallel 
Coomassie stained gels. * indicates a protein sample from a mouse that had not correctly received 
aldosterone. 
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Table I. Physiological parameters from WT and TK
-/-
 mice kept under a Na
+
-replete diet Values are 
means ± SE. Statistical significance between group was determined by unpaired Student t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
  WT (n=7) TK
-/-
 (n=7) p 
Renin activity  
(ng AngioI/h/ml) 868 ± 133 531 ± 71.4 
0.049 
Atrial natriuretic peptide (pg/ml) 325 ± 27    361 ±23 0.35 
Aldosterone (pM) 555 ± 172 504 ± 102 0.81 
Plasma 
Protein (g/l) 48.7 ± 0.9 47.5 ± 0.6 0.32 
Vu (mL/24h) 1.28 ± 0.61 1.45 ± 0.25 0.60 
Creatinine (mol/day) 4.28 ± 1.75 5.91 ± 1.05 0.34 
Aldosterone (nmol/mmol Creat) 1.74 ± 0.20 1.82 ± 0.13 0.76 
Na
+
 (mmol/mmol Creat) 23.6 ± 3.5 19.2 ± 1.8 0.29 
K
+
 (mmol/mmol Creat) 24.0 ± 3.1 19.1 ± 1.2 0.19 
Urine  
Cl
-
 (mmol/mmol Creat) 40.3 ± 0.9 36.5 ± 1.1 0.07 
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Table 2: Summary of densitometric analyses of data obtained by western-blot on cortical membrane 
fractions. Values are means ± SE. Statistical significance between group was determined by unpaired Student 
t-test. 
 
-ENaC Na/K-ATPase  
 
NaPi-
2a 
NHE3 NKCC2 NCC -
ENaC 
-
ENaC 85 kDa total   
subunit 
 
subunit 
WT (n=5) 100 ± 
12 
100 ± 
10 
100 ± 
30 
100 ± 
14 
100 ± 20 100 ± 6 100 ± 
12  
100 ± 
2 
100 ± 7 100 ± 20 
TK
-/- 
(n=5) 
93 ± 8 108 ± 
14 
100 ± 
18 
80 ± 10 86 ± 12 96 ± 8 122 ± 5 98 ± 2 80 ± 8 97 ± 17 
p N.S. N.S N.S. N.S. N.S. N.S. 0.07 N.S N.S. N.S. 
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Figure 1 
 
 
 
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 9, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
    17
Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Figure 9 
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